7mo6 | pdb_00007mo6

Guanosine Monophosphate Synthase from Aspergillus fumigatus Af293

spinqualitylabelsall models 7mo6, resolution 2.30Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 7mo6 is a 2 chain structure with sequence from Aspergillus fumigatus Af293. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Method: X-ray diffraction, Resolution 2.3Å Resources: FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT Function GUAA_ASPFU Publication Abstract from PubMed Purine biosynthesis is a fundamental cellular process that sustains life by maintaining the intracellular pool of purines for DNA/RNA synthesis and signal transduction. As an integral determinant of fungal survival and virulence, the enzymes in this metabolic pathway have been pursued as potential antifungal targets. Guanosine monophosphate (GMP) synthase has been identified as an attractive target as it is essential for virulence in the clinically prominent fungal pathogens Aspergillus fumigatus, Candida albicans and Cryptococcus neoformans. However, a lack of structural information on GMP synthase has hindered drug-design efforts. Here, the first structure of a GMP synthase of fungal origin, that from A. fumigatus (at 2.3 A resolution), is presented. Structural analysis of GMP synthase shows a distinct absence of the D1 dimerization domain that is present in the human homologue. Interestingly, A. fumigatus GMP synthase adopts a dimeric state, as determined by native mass spectrometry and gel-filtration chromatography, in contrast to the monomeric human homologue. Analysis of the substrate-binding pockets of A. fumigatus GMP synthase reveals key differences in the ATP- and XMP-binding sites that can be exploited for species-specific inhibitor drug design. Furthermore, the inhibitory activities of the glutamine analogues acivicin (IC50 = 16.6 +/- 2.4 microM) and 6-diazo-5-oxo-L-norleucine (IC50 = 29.6 +/- 5.6 microM) against A. fumigatus GMP synthase are demonstrated. Together, these data provide crucial structural information required for specifically targeting A. fumigatus GMP synthase for future antifungal drug-discovery endeavours. Structural insights into the antifungal drug target guanosine monophosphate synthase from Aspergillus fumigatus.,Nguyen S, Jovcevski B, Pukala TL, Bruning JB Acta Crystallogr D Struct Biol. 2022 Feb 1;78(Pt 2):248-259. doi:, 10.1107/S2059798321012031. Epub 2022 Jan 26. PMID:35102890 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See Also GMP synthase

Proteopedia Page Contributors and Editors (what is this?)

OCA